Products / Services

At present, the company has established extensive, in-depth and long-term cooperative relationships with many hospitals, and researches on multiple cancers such as lung cancer, colorectal cancer and gynecological tumors. The research direction covers the screening of early tumor markers and the prognosis. evaluation, tumor heterogeneity molecular classification and other fields, and

achieved fruitful results.

Genecast BRCA

Genecast BRCA is our NGS-based test for detecting BRCA1/2 gene mutation for breast cancer, ovarian cancer and pancreatic cancer. 


Genecast BRCA sequences exons and splicing regions of the BRCA1/2 gene in DNA extracted from blood cell samples and oral swab samples. 


It combines genetic testing by sequencing the DNA of blood cell samples or oral swab samples with analysis against international authoritative databases and our proprietary algorithm, to provide a targeted therapy recommendation as well as cancer risk assessment for patients based on American College of Medical Genetics and Genomics (“ACMG”) and NCCN guidelines.